13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q1 2023 · Filed February 9, 2023 · Accession 0001567619-23-002139
Total Value
$343,711
Positions
22
Other Managers
1
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Legend Biotech Corporation | LEGN | 1,629,173 | $81,328 | 23.66% |
| 2 | CVRx, Inc. | CVRX | 3,495,575 | $64,144 | 18.66% |
| 3 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $43,300 | 12.60% |
| 4 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $34,095 | 9.92% |
| 5 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $26,721 | 7.77% |
| 6 | Xencor, Inc. | XNCR | 748,062 | $19,480 | 5.67% |
| 7 | Procept BioRobotics Corporation | PRCT | 357,939 | $14,869 | 4.33% |
| 8 | Fusion Pharmaceuticals Inc. | 36118A100 | 3,670,516 | $11,562 | 3.36% |
| 9 | Cue Health, Inc. | 229790100 | 5,548,864 | $11,486 | 3.34% |
| 10 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $10,043 | 2.92% |
| 11 | Point Biopharma Global Inc. | 730541109 | 1,000,000 | $7,290 | 2.12% |
| 12 | Vor Biopharma, Inc. | VOR | 1,074,658 | $7,146 | 2.08% |
| 13 | Adicet Bio, Inc. | ACET | 728,944 | $6,517 | 1.90% |
| 14 | Aldeyra Therapeutics, Inc. | ALDX | 394,834 | $2,748 | 0.80% |
| 15 | Nano-X Imaging Ltd. | NNOX | 196,228 | $1,448 | 0.42% |
| 16 | SomaLogic, Inc. | 83444K105 | 281,052 | $705 | 0.21% |
| 17 | BiomX Inc. | PHGE | 2,133,402 | $398 | 0.12% |
| 18 | Clearside Biomedical, Inc. | CLSDQ | 169,629 | $190 | 0.06% |
| 19 | Tracon Pharmaceuticals, Inc. | 89237H209 | 84,003 | $125 | 0.04% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $56 | 0.02% |
| 21 | Catalyst Biosciences, Inc. | 14888D208 | 66,951 | $35 | 0.01% |
| 22 | Graybug Vision, Inc. | 38942Q103 | 49,547 | $25 | 0.01% |